NDRA
- ENDRA Life Sciences Inc.
()
Overview
Company Summary
ENDRA Life Sciences Inc. is a medical technology company that specializes in developing and commercializing advanced diagnostic imaging solutions. The company focuses on the development of thermo-acoustic enhanced ultrasound (TAEUS) technology for a variety of clinical applications.
TAEUS technology represents a breakthrough in medical imaging as it combines ultrasound and thermo-acoustic techniques to deliver high-resolution images with improved tissue differentiation. This innovative approach allows for non-invasive visualization and characterization of tissue properties, leading to enhanced diagnostic capabilities.
ENDRA Life Sciences aims to provide physicians and healthcare professionals with a more accurate and efficient tool for diagnosing and assessing a range of medical conditions and diseases. The company's primary focus is on liver disease, which is a global health concern due to the rising prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
With its TAEUS technology, ENDRA Life Sciences aims to offer a more cost-effective and scalable solution for liver disease diagnosis, monitoring, and treatment evaluation. The company is actively engaged in developing partnerships and collaborations to further the application of their technology in other clinical areas such as oncology, cardiovascular diseases, and thyroid disease.
In summary, ENDRA Life Sciences Inc. is dedicated to transforming the field of medical imaging through the development and commercialization of TAEUS technology. The company's goal is to provide healthcare professionals with innovative tools to improve the diagnosis and management of various medical conditions, initially focusing on liver disease.